The Cooper Companies, Inc (COO)
🔔 Watch stock
Stock Watch
Stock Watch will tell you what changes at The Cooper Companies, Inc.
Later $1 a month per stock — signing up is free, and you'll be the first to know when it launches.
Trading Day
Key levels of the most recently completed trading day — not a live quote.
52-Week Range
Current price 72.30 $ — 53% of the range above the low.
Lowest and highest closing price over the last 52 weeks. The marker shows where the current price sits within that range: close to the high speaks for strength, close to the low for weakness.
Basics
Performance
Technical Indicators
Calculated from the price history · as of 08/03/2026
Valuation
Profitability
Balance Sheet & Safety
Growth
Dividend
This stock currently pays no dividend.
Quality & Screener
AI Rating
–Not yet rated — we only show a category once an SEC-backed file with at least two cited passages is available. How the Rating Is Built
Highlighted are things our editorial team noticed: green = stands out as strong, red = deserves a closer look. No single metric is a verdict on its own — always read it in context.
Analysts & Price Target
The price target sits 12.3% above the current price.
- Consensus
- Sell
- Analyst Ratings
- 19
Combined picture of the price targets and recommendations of every analyst covering the stock. Price targets are expectations for the next 12 months, not promises — and they often follow the price rather than predict it.
Estimates by Fiscal Year
| Fiscal Year | EPS Estimate ($) | EPS Range ($) | Revenue Estimate ($M) | Expected Growth | Analysts |
|---|---|---|---|---|---|
| 10/31/2026 | 4.63 | 4.57 – 4.67 | 4,307 | 12.3% | 16 |
| 10/31/2027 | 5.00 | 4.88 – 5.10 | 4,517 | 8.0% | 16 |
Average of the analyst estimates for the coming fiscal years. The range shows how far the most optimistic and the most cautious estimate sit apart — the wider it is, the less certain the expectation.
Next Reporting Date
- Expected Earnings per Share
- 1.11 $
Expected date of the next quarterly or annual figures. Dates do shift occasionally — only the invitation issued by the company is binding.
Revenue & Profit
Cash Flow
Balance Sheet
Margins
Per Share
Click the chart or tab into it, then use ← and → to step through the periods.
None of the selected stocks reports this metric. Pick another metric or switch between annual and quarterly.
· Total · per year
These companies report in different currencies — switch on “Indexed” or pick a margin for a fair comparison.
The figures could not be loaded right now.
Source: fundamental data
Quarterly Figures
| Quarter | EPS (Earnings Per Share) | EPS YoY (%) | Sales ($M) | Sales YoY (%) | Net Margin (%) | OCF ($M) | FCF ($M) |
|---|---|---|---|---|---|---|---|
| 2025: Q1 | 0.52 | 27.60 | 965 | 3.60 | 10.80 | 191 | 101 |
| 2025: Q2 | 0.44 | -1.40 | 1,002 | 6.30 | 8.70 | 96 | 18 |
| 2025: Q3 | 0.49 | -6.10 | 1,060 | 5.70 | 9.30 | 261 | 165 |
| 2025: Q4 | 0.43 | -26.90 | 1,065 | 4.60 | 7.90 | 248 | 150 |
| 2026: Q1 | 0.66 | 28.30 | 1,024 | 6.20 | 12.80 | 261 | 159 |
| 2026: Q2 | -0.40 | -191.40 | 1,082 | 7.90 | -7.20 | 183 | 96 |
- EPS (Earnings Per Share):
- Quarterly profit divided by the total share count — how much of the profit works out to a single share.
- YoY (Year over Year):
- Change versus the same quarter a year ago — this is how you compare without seasonal distortion (e.g. the holiday shopping season).
- Sales:
- All revenue for the quarter, before any costs are deducted — the top line of the income statement.
- Net Margin:
- What percentage of sales is left over as profit in the end. Negative means the company is posting a loss.
- OCF (Operating Cash Flow):
- The cash that actually flows into the till from the core business during the quarter — harder to dress up than book profit.
- FCF (Free Cash Flow):
- Operating cash flow minus capital expenditures — the money that's genuinely free to use, say for paying down debt, buybacks, or dividends.
Annual Figures
| Fiscal Year | Revenue ($M) | EBIT ($M) | Net Income ($M) | EPS ($) | Operating Cash Flow ($M) | Equity ($M) | Total Assets ($M) |
|---|---|---|---|---|---|---|---|
| 2016 | 1,967 | 324 | 274 | 1.40 | 510 | 2,696 | 4,476 |
| 2017 | 2,139 | 429 | 373 | 1.88 | 594 | 3,176 | 4,859 |
| 2018 | 2,533 | 403 | 140 | 0.70 | 669 | 3,308 | 6,113 |
| 2019 | 2,653 | 547 | 467 | 2.33 | 713 | 3,628 | 6,275 |
| 2020 | 2,431 | 312 | 238 | 1.20 | 487 | 3,825 | 6,738 |
| 2021 | 2,923 | 506 | 2,945 | 14.77 | 739 | 6,942 | 9,606 |
| 2022 | 3,308 | 508 | 386 | 1.94 | 692 | 7,175 | 11,492 |
| 2023 | 3,593 | 533 | 294 | 1.48 | 608 | 7,551 | 11,659 |
| 2024 | 3,895 | 706 | 392 | 1.96 | 709 | 8,083 | 12,315 |
| 2025 | 4,092 | 683 | 375 | 1.87 | 796 | 8,239 | 12,395 |
Fiscal years from the audited annual reports, oldest first. EBIT is the operating profit before interest and taxes; total assets are everything the company owns.
About the Company
The Cooper Companies, Inc. entwickelt, fertigt und vermarktet mit ihren Tochtergesellschaften Produkte für Kontaktlinsenträger.
| CEO Insider Trades (12 Mo.) | buying own stock |
|---|---|
| Employees | 15,000 |
| Headquarters | San Ramon, CA |
| Address | 6101 Bollinger Canyon Road, 94583 San Ramon, United States |
| Phone | 925 460 3600 |
| Website | coopercos.com |
| IPO Date | 30. Dec 1983 |
| ISIN | US2166485019 |
| Stock Split | 4:1 on 02/20/2024 |
Management
| Name | Title | Birth Year |
|---|---|---|
| Albert G. White III | President, CEO & Non-Independent Director | 1970 |
| Brian G. Andrews | Executive VP, CFO, Treasurer & Principal Accounting Officer | 1979 |
| Daniel G. McBride Esq. | Executive VP, COO General Counsel & Secretary | 1964 |
| Holly R. Sheffield | President of CooperSurgical, Inc. | 1971 |
| Gerard H. Warner III | President of CooperVision, Inc. | 1965 |
| Kim Duncan | Vice President of Investor Relations & Risk Management | – |
Executives per the latest required filings; titles kept in their original language. Source: fundamental data.
Chart
Interactive price chart (TradingView).
Data as of: July 31, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.